Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

RNAZ

Transcode Therapeutics, Inc.

CIK 0001829635 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$9.60
↑ 1.72 (21.84%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$9.12M
P/E Ratio
-0.23
EPS
-52.59
Dividend Yield
Not covered
52W Position
34%
Beta
0.87

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
7.29
P/S
Not covered
EV/Revenue
Not covered
ROE
-3225.2%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 34%
$3.82$20.99

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$34.66M
Total Assets
$162.40M
Free Cash Flow
-$19.52M

Recent news